Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH Brain Development Cohorts (NBDC), (National Institute on Drug Abuse), 89019-89020 [2024-26138]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 218 / Tuesday, November 12, 2024 / Notices
Contact Person: Erica L. Brown, Ph.D.,
Director, Division of Extramural Activities,
National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 2AN24C, Bethesda,
MD 20892, 301–594–4499, erica.brown@
nih.gov.
Members of the public are welcome to
provide written comments by emailing
NIGMS_DEA_Mailbox@nigms.nih.gov at least
3 days in advance of the meeting. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nigms.nih.gov/About/Council, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program No. 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: November 5, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–26074 Filed 11–8–24; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Data Use Certification for the
NIH Brain Development Cohorts
(NBDC), (National Institute on Drug
Abuse)
ACTION:
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSKJM1Z7X2PROD with NOTICES
[FR Doc. 2024–26110 Filed 11–8–24; 8:45 am]
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group; Acquired Immunodeficiency
Syndrome Research Study Section Acquired
Immunodeficiency Syndrome Research
Study Section.
Date: December 6, 2024.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3D32,
Rockville, MD 20892 (Video Assisted
Meeting).
Jkt 265001
National Institutes of Health,
HHS.
National Institutes of Health
16:35 Nov 08, 2024
Dated: November 5, 2024
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
AGENCY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
Contact Person: Robert C. Unfer, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3D32, Rockville, MD
20892, (240) 669–5035, robert.unfer@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Notice.
The purpose of this revision
is to clarify inclusion of the HBCD
Study, to update data use terms and
conditions, and to request a progress
report statement at the time of renewal.
Burden levels remain unchanged.
In compliance with the requirement
of the Paperwork Reduction Act of 1995
to provide opportunity for public
comment on proposed data collection
projects, the National Institute on Drug
Abuse (NIDA) will publish periodic
summaries of proposed projects to be
submitted to the Office of Management
and Budget (OMB) for review and
approval.
SUMMARY:
Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
DATES:
To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Dr. Elizabeth A. Hoffman,
Associate Director, Division of
Extramural Research, National Institute
on Drug Abuse, 3WFN Room 09C75
MSC 6021, Gaithersburg, MD 20877, or
call non-toll-free number (301) 594–
2265 or Email your request, including
your address to: elizabeth.hoffman@
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
89019
nih.gov. Formal requests for additional
plans and instruments must be
requested in writing.
SUPPLEMENTARY INFORMATION: Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimizes
the burden of the collection of
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Proposed Collection Title: Data Use
Certification for the NIH BRAIN
Development Cohorts (NBDC), (NIDA)
0925–0780, exp., date 10/31/2026
REVISION, National Institute on Drug
Abuse (NIDA), National Institutes of
Health (NIH).
Need and Use of Information
Collection: The purpose of this proposal
is to inform data requestors about terms
and conditions for using data generated
by the Adolescent Brain Cognitive
Development (SM) (ABCD) Study and the
Healthy Brain and Child Development
(HBCD) Study, collectively known as
the NIH Brain Development Cohorts
(NBDC), and to obtain signed
agreements from requestors and their
institutional officials attesting to their
commitment to abide by the data use
terms and conditions. These include
using data for research purposes;
adhering to human subjects research
requirements; not distributing the data
to non-authorized users; minimizing
risk of participant identifiability; using
data ethically and responsibly; and
keeping the data secure. Recipients
must include a brief description of their
research project and submit their signed
data use agreements to the data
repository to gain access to NBDC Study
data. Recipients who plan to conduct
research studies specifically on
American Indian/Alaska Native (AI/AN)
populations must submit an additional
signed data use certification.
OMB approval is requested for 3
years. There are no costs to respondents
E:\FR\FM\12NON1.SGM
12NON1
89020
Federal Register / Vol. 89, No. 218 / Tuesday, November 12, 2024 / Notices
other than their time. The total
estimated annualized burden hours are
2,000.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Average time
per response
(in hours)
Total annual
burden hour
Individuals (standard DUC form) .....................................................................
Individuals (additional AI/AN DUC form when needed) ..................................
1,800
200
1
1
1
1
1,800
200
Total ..........................................................................................................
......................
2,000
........................
2,000
Lanette A. Palmquist,
Project Clearance Liaison, National Institute
on Drug Abuse, National Institutes of Health.
[FR Doc. 2024–26138 Filed 11–8–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Fogarty International Center; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Fogarty International
Center Advisory Board.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below.
Individuals who plan to attend inperson or view the virtual meeting and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session can be accessed from the
Fogarty International Center website
(https://www.fic.nih.gov/About/
Advisory/Pages/default.aspx).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses per
respondent
Name of Committee: Fogarty International
Center Advisory Board.
Date: February 10–11, 2025.
Closed: February 10, 2025, 1:00 p.m. to
4:00 p.m.
Agenda: To review and evaluate the
second level of grant applications.
Address: Fogarty International Center,
National Institutes of Health, Lawton Chiles
VerDate Sep<11>2014
16:35 Nov 08, 2024
Jkt 265001
International House (Stone House), 16 Center
Drive, Conference Room, Bethesda, MD
20892 (In-person and Virtual Meeting).
Open: February 11, 2025, 9:00 a.m. to 3:00
p.m.
Agenda: Update and discussion of current
and planned Fogarty International Center
activities.
Address: Fogarty International Center,
National Institutes of Health, Lawton Chiles
International House (Stone House), 16 Center
Drive, Conference Room, Bethesda, MD
20892 (In-person and Virtual Meeting).
Meeting Access: https://www.fic.nih.gov/
About/Advisory/Pages/default.aspx.
Contact Person: Kristen Weymouth,
Executive Secretary, Fogarty International
Center, 31 Center Drive, Room B2C02,
Bethesda, MD 20892, 301–495–1415,
kristen.weymouth@nih.gov.
Any interested person may file written
comments with the committee by
forwarding the statement to the Contact
Persons listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/
about-nih/visitor-information/
campusaccess-security for entrance into
on-campus and off-campus facilities. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal
facility will be asked to show one form
of identification (for example, a
government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.fic.nih.gov/About/Advisory/Pages/
default.aspx, where an agenda and any
additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.106, Minority International
Research Training Grant in the Biomedical
and Behavioral Sciences; 93.154, Special
International Postdoctoral Research Program
in Acquired Immunodeficiency Syndrome;
93.168, International Cooperative
Biodiversity Groups Program; 93.934, Fogarty
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
International Research Collaboration Award;
93.989, Senior International Fellowship
Awards Program, National Institutes of
Health, HHS)
Dated: November 5, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–26112 Filed 11–8–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
Date: January 29–30, 2025.
Open: January 29, 2025, 8:30 a.m. to 12:00
p.m.
E:\FR\FM\12NON1.SGM
12NON1
]]>Agencies
[Federal Register Volume 89, Number 218 (Tuesday, November 12, 2024)]
[Notices]
[Pages 89019-89020]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-26138]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request; Data Use
Certification for the NIH Brain Development Cohorts (NBDC), (National
Institute on Drug Abuse)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The purpose of this revision is to clarify inclusion of the
HBCD Study, to update data use terms and conditions, and to request a
progress report statement at the time of renewal. Burden levels remain
unchanged.
In compliance with the requirement of the Paperwork Reduction Act
of 1995 to provide opportunity for public comment on proposed data
collection projects, the National Institute on Drug Abuse (NIDA) will
publish periodic summaries of proposed projects to be submitted to the
Office of Management and Budget (OMB) for review and approval.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 60 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, submit comments in writing, or
request more information on the proposed project, contact: Dr.
Elizabeth A. Hoffman, Associate Director, Division of Extramural
Research, National Institute on Drug Abuse, 3WFN Room 09C75 MSC 6021,
Gaithersburg, MD 20877, or call non-toll-free number (301) 594-2265 or
Email your request, including your address to:
[email protected]. Formal requests for additional plans and
instruments must be requested in writing.
SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: written comments and/or suggestions
from the public and affected agencies are invited to address one or
more of the following points: (1) Whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have practical
utility; (2) The accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) Ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) Ways
to minimizes the burden of the collection of information on those who
are to respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
Proposed Collection Title: Data Use Certification for the NIH BRAIN
Development Cohorts (NBDC), (NIDA) 0925-0780, exp., date 10/31/2026
REVISION, National Institute on Drug Abuse (NIDA), National Institutes
of Health (NIH).
Need and Use of Information Collection: The purpose of this
proposal is to inform data requestors about terms and conditions for
using data generated by the Adolescent Brain Cognitive Development
\(SM)\ (ABCD) Study and the Healthy Brain and Child Development (HBCD)
Study, collectively known as the NIH Brain Development Cohorts (NBDC),
and to obtain signed agreements from requestors and their institutional
officials attesting to their commitment to abide by the data use terms
and conditions. These include using data for research purposes;
adhering to human subjects research requirements; not distributing the
data to non-authorized users; minimizing risk of participant
identifiability; using data ethically and responsibly; and keeping the
data secure. Recipients must include a brief description of their
research project and submit their signed data use agreements to the
data repository to gain access to NBDC Study data. Recipients who plan
to conduct research studies specifically on American Indian/Alaska
Native (AI/AN) populations must submit an additional signed data use
certification.
OMB approval is requested for 3 years. There are no costs to
respondents
[[Page 89020]]
other than their time. The total estimated annualized burden hours are
2,000.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Type of respondent Number of responses per per response Total annual
respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Individuals (standard DUC form).................. 1,800 1 1 1,800
Individuals (additional AI/AN DUC form when 200 1 1 200
needed).........................................
--------------------------------------------------------------
Total........................................ ............ 2,000 .............. 2,000
----------------------------------------------------------------------------------------------------------------
Lanette A. Palmquist,
Project Clearance Liaison, National Institute on Drug Abuse, National
Institutes of Health.
[FR Doc. 2024-26138 Filed 11-8-24; 8:45 am]
BILLING CODE 4140-01-P
